News | May 02, 2026
FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies
The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
Subscribe To Our Newsletter & Stay Updated
